Literature DB >> 15170160

Successful use of Campath-1H in the treatment of steroid refractory liver GvHD.

F Wandroo, B Auguston, M Cook, C Craddock, P Mahendra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15170160     DOI： 10.1038/sj.bmt.1704573

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  4 in total

1.  The successful use of alemtuzumab for treatment of steroid-refractory acute graft-versus-host disease in pediatric patients.

Authors:  Pooja Khandelwal; Julia Lawrence; Alexandra H Filipovich; Stella M Davies; Jacob J Bleesing; Michael B Jordan; Parinda Mehta; Sonata Jodele; Michael S Grimley; Ashish Kumar; Kasiani Myers; Rebecca A Marsh
Journal:  Pediatr Transplant       Date:  2013-10-30

Review 2.  How I treat refractory acute GVHD.

Authors:  H Joachim Deeg
Journal:  Blood       Date:  2007-01-18       Impact factor: 22.113

3.  A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Pooja Khandelwal; Chie Emoto; Tsuyoshi Fukuda; Alexander A Vinks; Lisa Neumeier; Christopher E Dandoy; Javier El-Bietar; Sharat Chandra; Stella M Davies; Jacob J Bleesing; Michael B Jordan; Parinda A Mehta; Sonata Jodele; Michael S Grimley; Ashish Kumar; Kasiani C Myers; Rebecca A Marsh
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-21       Impact factor: 5.742

Review 4.  Acute graft-versus-host disease: new treatment strategies.

Authors:  Sophie Paczesny; Sung W Choi; James L M Ferrara
Journal:  Curr Opin Hematol       Date:  2009-11       Impact factor: 3.284
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.